Glycans in Diseases and Therapeutics
Glycomedicine functions as essential role in cell-cell adhesion i.e. a device used by cells of the immune system through sugar-binding proteins called lectins, which classify precise carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play leading roles in various biological phenomena as well as in numerous pathophysiological procedures. Several scientists have now understood that glycosylation, i.e. the count of glycans to a protein backbone, is the most plentiful post translational alteration responses and is a major field of research and sometimes they require a glycobiology method to be exploited
- Glycomedicine
- Transfusion medicine
- Congenital disorders of glycosylation (CDG)
- Cancer biomarkers
- Cardiovascular diseases
- Cardiac arrest
- Cancer associated coagulopathies
Related Conference of Glycans in Diseases and Therapeutics
17th International Conference on Tissue Science and Regenerative Medicine
Glycans in Diseases and Therapeutics Conference Speakers
Recommended Sessions
- Biochemistry
- Evolution of Glycan Diversity
- Genomics and Metabolomics
- Glycan’s
- Glycans in Diseases and Therapeutics
- Glycans in Drug Design
- Glycobiology
- Glycochemistry
- Glycoimmunology
- Glycoinformatics
- Glycolipids and Glycopeptides
- Glyconeurobiology
- Glycopathology
- Glycoscience
- Proteoglycan and Sialic acid
- Recent Advances in Glycobiology
- Synthesis and Biological Role of Glycans